Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) EPS (Basic) (2016 - 2020)

Forte Biosciences (FBRX) has disclosed EPS (Basic) for 5 consecutive years, with $9515.1 as the latest value for Q4 2020.

  • On a quarterly basis, EPS (Basic) rose 2114566.67% to $9515.1 in Q4 2020 year-over-year; TTM through Dec 2020 was -$6.32, a 134.94% decrease, with the full-year FY2024 number at -$12.17, up 51.16% from a year prior.
  • EPS (Basic) was $9515.1 for Q4 2020 at Forte Biosciences, up from -$0.45 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $9515.1 in Q4 2020 to a low of -$9520.0 in Q2 2020.
  • A 5-year average of -$1.62 and a median of -$0.76 in 2019 define the central range for EPS (Basic).
  • Biggest YoY gain for EPS (Basic) was 2114566.67% in 2020; the steepest drop was 1322122.22% in 2020.
  • Forte Biosciences' EPS (Basic) stood at -$3.83 in 2016, then skyrocketed by 85.64% to -$0.55 in 2017, then crashed by 74.55% to -$0.96 in 2018, then skyrocketed by 53.12% to -$0.45 in 2019, then surged by 2114566.67% to $9515.1 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's EPS (Basic) are $9515.1 (Q4 2020), -$0.45 (Q3 2020), and -$9520.0 (Q2 2020).